# US 2025/0152073 A1 · Detecting nonsustained ventricular tachycardia in a wearable cardioverter defibrillator

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0152073 A1
- Document ID: US20250152073A1
- Status: Published application
- Kind: A1
- Application number: 19/023,780
- Filed: 2025-01-16
- Published: 2025-05-15
- Earliest claimed: 2020-08-21
- Assignees: West Affum Holdings DAC
- Applicants: West Affum Holdings DAC
- Inventors: Jaeho Kim; Joseph Sullivan
- Web page: https://patentgrep.com/patent/US20250152073A1

## CPC

- A61B 5/366: Detecting abnormal QRS complex, e.g. widening
- A61B 5/02455: {provided with high/low alarm devices}
- A61B 5/352: Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
- A61B 5/363: Detecting tachycardia or bradycardia
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/6805: {Vests, e.g. shirts or gowns}
- A61B 5/7246: {using correlation, e.g. template matching or determination of similarity}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61N 1/3904: {External heart defibrillators [EHD]}
- A61N 1/3943: {for threshold determination}
- A61N 1/395: {for treating atrial fibrillation}
- A61N 1/3987: {characterised by the timing or triggering of the shock}
- A61B 5/02405: {Determining heart rate variability}
- A61B 5/33: specially adapted for cooperation with other devices
- A61B 5/332: Portable devices specially adapted therefor
- A61B 5/6843: {Monitoring or controlling sensor contact pressure}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A method to monitor a patient's heart health is described. The method may include processing at least one electrocardiogram (ECG) signal and diagnosing an episode of nonsustained ventricular tachycardia (NSVT) based at least in part on the processing of the at least one ECG signal. In some embodiments, the NSVT episode may satisfy an NSVT time duration and a QRS criterion. The NSVT time duration may be between 5 seconds and 15 seconds. In some instances, the QRS criterion may be a temporary QRS template of two sequential incoming QRS complexes. In some embodiments, the method may determine a similarity between the temporary QRS template and at least two subsequent QRS complexes by calculating a feature correlation coefficient between the QRS template and the subsequent QRS complexes.

## Claims

### Claim at position 1

1-14. (canceled)

### Claim 15

A wearable cardioverter defibrillator (WCD), comprising:
a support structure wearable by a patient;
a processor coupled to the support structure; and
a discharge circuit configured to discharge a stored electrical charge through a body of the patient, the discharge circuit in communication with the processor;
the processor configured to:
receive a first electrocardiogram (ECG) signal;
receive a second ECG signal;
detect a first QRS complex in the first ECG signal;
detect a second QRS complex in the second ECG signal;
calculate a Feature Correlation Coefficient (FCC) based, at least in part, on the first QRS complex and the second QRS complex;
determine that the first ECG signal and the second ECG signal are indicative of an episode of sustained ventricular tachycardia (SVT) based, at least in part, on the calculated FCC; and
provide therapy to a heart of the patient based, at least in part, on a determination that the episode of SVT is indicated.

### Claim 16 (depends on 15)

The WCD of claim 15, wherein the episode of SVT satisfies a QRS criterion.

### Claim 17

(canceled)

### Claim 18 (depends on 16)

The WCD of claim 16, wherein the QRS criterion is a temporary QRS template of two sequential incoming QRS complexes.

### Claim 19 (depends on 18)

The WCD of claim 18, wherein the processor is further configured to:
determine a similarity between the temporary QRS template and at least two subsequent QRS complexes by calculating the FCC between the temporary QRS template and the subsequent QRS complexes.

### Claim at position 7

20-22. (canceled)

### Claim 23 (depends on 15)

The WCD of claim 15, wherein a series of detected QRS signals has a similar calculated QRS morphology.

### Claim 24 (depends on 23)

The WCD of claim 23, wherein the QRS morphology is calculated using the FCC of at least two incoming sequential QRS complexes.

### Claim 25 (depends on 15)

The WCD of claim 15, wherein the episode of SVT is detected, at least in part, when a series of detected QRS complexes comprising the first QRS complex and/or the second QRS complex has a similar normal sinus rhythm (NSR) morphology.

### Claim 26

(canceled)

### Claim 27

(canceled)

### Claim 28 (depends on 15)

The WCD of claim 15, wherein the processor is further configured to:
store the episode of SVT based, at least in part, on the determination.

### Claim 29

(canceled)

### Claim 30

A wearable medical device, comprising:
a support structure wearable by a patient;
a processor coupled to the support structure; and
a discharge circuit configured to discharge a stored electrical charge through a body of the patient, the discharge circuit in communication with the processor;
the processor configured to:
receive a first electrocardiogram (ECG) signal;
receive a second ECG signal;
detect a first QRS complex in the first ECG signal;
detect a second QRS complex in the second ECG signal;
calculate a Feature Correlation Coefficient (FCC) based, at least in part, on the first QRS complex and the second QRS complex;
determine that the first ECG signal and the second ECG signal are indicative of an episode of sustained ventricular tachycardia (SVT) based, at least in part, on the calculated FCC; and
provide therapy to a heart of the patient based, at least in part, on a determination that the episode of SVT is indicated.

### Claim 31 (depends on 30)

The wearable medical device of claim 30, wherein the episode of SVT satisfies a QRS criterion.

### Claim 32 (depends on 31)

The wearable medical device of claim 31, wherein the QRS criterion is a temporary QRS template of two sequential incoming QRS complexes.

### Claim 33

A wearable medical device, comprising:
a support structure wearable by a patient;
a processor coupled to the support structure; and
a discharge circuit configured to discharge a stored electrical charge through a body of the patient, the discharge circuit in communication with the processor;
the processor configured to:
process at least one electrocardiogram (ECG) signal received from an external electrode;
generate a temporary QRS template of two sequential incoming QRS complexes from the ECG signal;
determine a similarity between the temporary QRS template and at least two subsequent QRS complexes by calculating a feature correlation coefficient (FCC) between the temporary QRS template and the at least two subsequent QRS complexes;
categorize an episode as potential non-sustained ventricular tachycardia (NSVT) or a sustained ventricular tachycardia (SVT) based, at least in part, on the similarity between the temporary QRS template and the at least two subsequent QRS complexes;
store the categorized episode of potential NSVT; and
access the categorized episode of potential NSVT to determine a risk for the patient to develop SVT, the determination of the risk of SVT resulting in providing therapy for treatment of a heart of the patient.

### Claim 34 (depends on 33)

The wearable medical device of claim 33, wherein the episode of potential NSVT is categorized based, at least in part, on when an NSVT time duration and a QRS criterion are satisfied.

### Claim 35 (depends on 34)

The wearable medical device of claim 34, wherein the NSVT time duration is between 5 seconds and 15 seconds.

### Claim 36 (depends on 33)

The wearable medical device of claim 33, wherein the episode of potential NSVT exceeds a heart rate threshold and an NSVT time threshold.

### Claim 37 (depends on 36)

The wearable medical device of claim 36, wherein the heart rate threshold is 170 BPM.

### Claim 38 (depends on 33)

The wearable medical device of claim 33, wherein the episode of potential NSVT satisfies and R-R stability criterion.

### Claim 39 (depends on 38)

The wearable medical device of claim 38, wherein the R-R stability criterion is satisfied when a difference between at least two consecutive R-R intervals is less than 20 milliseconds.
